CCDC90B
gene geneOn this page
Also known as MDS025MDS011
Summary
CCDC90B (coiled-coil domain containing 90B, HGNC:28108) is a protein-coding gene on chromosome 11q14.1, encoding Coiled-coil domain-containing protein 90B, mitochondrial (Q9GZT6).
Located in mitochondrion.
Source: NCBI Gene 60492 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 57 total
- MANE Select transcript:
NM_021825
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28108 |
| Approved symbol | CCDC90B |
| Name | coiled-coil domain containing 90B |
| Location | 11q14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MDS025, MDS011 |
| Ensembl gene | ENSG00000137500 |
| Ensembl biotype | protein_coding |
| OMIM | 620753 |
| Entrez | 60492 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 10 nonsense_mediated_decay, 10 protein_coding, 3 retained_intron, 2 protein_coding_CDS_not_defined
ENST00000260054, ENST00000455220, ENST00000525503, ENST00000525504, ENST00000525916, ENST00000526265, ENST00000526631, ENST00000527025, ENST00000527495, ENST00000528149, ENST00000529073, ENST00000529312, ENST00000529611, ENST00000529689, ENST00000529745, ENST00000529856, ENST00000530253, ENST00000533761, ENST00000534753, ENST00000874525, ENST00000874526, ENST00000874527, ENST00000874528, ENST00000915430, ENST00000915431
RefSeq mRNA: 6 — MANE Select: NM_021825
NM_001286116, NM_001286117, NM_001286118, NM_001286119, NM_001286120, NM_021825
CCDS: CCDS66190, CCDS8266
Canonical transcript exons
ENST00000529689 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002144130 | 83259081 | 83261966 |
| ENSE00002197186 | 83285873 | 83286367 |
| ENSE00003492257 | 83273951 | 83273992 |
| ENSE00003542415 | 83265865 | 83265979 |
| ENSE00003551859 | 83278726 | 83278829 |
| ENSE00003573079 | 83274639 | 83274740 |
| ENSE00003574461 | 83273647 | 83273700 |
| ENSE00003674065 | 83273793 | 83273864 |
| ENSE00003684979 | 83280141 | 83280260 |
Expression profiles
Bgee: expression breadth ubiquitous, 293 present calls, max score 97.89.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 43.7169 / max 775.5929, expressed in 1819 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 121599 | 28.0208 | 1807 |
| 121602 | 8.3502 | 1786 |
| 121597 | 2.3976 | 1241 |
| 121601 | 2.1183 | 1347 |
| 121598 | 1.2846 | 873 |
| 121600 | 0.5062 | 269 |
| 121596 | 0.3917 | 185 |
| 121603 | 0.3705 | 152 |
| 121595 | 0.2768 | 124 |
Top tissues by expression
293 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 97.89 | gold quality |
| ganglionic eminence | UBERON:0004023 | 97.16 | gold quality |
| ventricular zone | UBERON:0003053 | 97.08 | gold quality |
| adrenal tissue | UBERON:0018303 | 97.01 | gold quality |
| calcaneal tendon | UBERON:0003701 | 96.92 | gold quality |
| sperm | CL:0000019 | 96.53 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.35 | gold quality |
| left testis | UBERON:0004533 | 96.26 | gold quality |
| right testis | UBERON:0004534 | 96.18 | gold quality |
| spinal cord | UBERON:0002240 | 95.98 | gold quality |
| corpus callosum | UBERON:0002336 | 95.94 | gold quality |
| male germ cell | CL:0000015 | 95.77 | gold quality |
| testis | UBERON:0000473 | 95.64 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.59 | gold quality |
| tendon | UBERON:0000043 | 95.45 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.32 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 95.05 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.80 | gold quality |
| right coronary artery | UBERON:0001625 | 94.80 | gold quality |
| adrenal gland | UBERON:0002369 | 94.78 | gold quality |
| adrenal cortex | UBERON:0001235 | 94.53 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.50 | gold quality |
| endothelial cell | CL:0000115 | 94.43 | gold quality |
| embryo | UBERON:0000922 | 94.42 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.36 | gold quality |
| amniotic fluid | UBERON:0000173 | 94.28 | gold quality |
| tibia | UBERON:0000979 | 93.98 | gold quality |
| left coronary artery | UBERON:0001626 | 93.45 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 93.43 | gold quality |
| substantia nigra | UBERON:0002038 | 93.31 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.66 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
97 targeting CCDC90B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-219A-5P | 99.91 | 73.36 | 735 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-4782-3P | 99.88 | 73.31 | 735 |
| HSA-MIR-6766-3P | 99.88 | 73.38 | 732 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-202-3P | 99.84 | 71.41 | 1290 |
| HSA-MIR-6715A-3P | 99.83 | 68.05 | 1473 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
Literature-anchored findings (GeneRIF, showing 1)
- Using MCUR1, the functionally characterized paralog of study the role of individual domains, results find that the conserved head domain in CCDC90B interacts directly with mitochondrial calcium uniporter and is destabilized upon Ca(2+) binding. (PMID:30612859)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc90b | ENSDARG00000044626 |
| mus_musculus | Ccdc90b | ENSMUSG00000030613 |
| rattus_norvegicus | Ccdc90b | ENSRNOG00000009462 |
Paralogs (1): MCUR1 (ENSG00000050393)
Protein
Protein identifiers
Coiled-coil domain-containing protein 90B, mitochondrial — Q9GZT6 (reviewed: Q9GZT6)
All UniProt accessions (10): Q9GZT6, E9PKQ5, E9PMQ7, E9PNI8, E9PPJ7, E9PRC2, E9PSG6, H0YD95, H0YF06, J3KN19
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with MCU.
Subcellular location. Mitochondrion membrane.
Similarity. Belongs to the CCDC90 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9GZT6-1 | 1 | yes |
| Q9GZT6-2 | 2 | |
| Q9GZT6-3 | 3 |
RefSeq proteins (6): NP_001273045, NP_001273046, NP_001273047, NP_001273048, NP_001273049, NP_068597* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024461 | CCDC90-like | Family |
Pfam: PF07798
UniProt features (11 total): helix 3, splice variant 2, transit peptide 1, chain 1, transmembrane region 1, coiled-coil region 1, sequence variant 1, turn 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6H9M | X-RAY DIFFRACTION | 2.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9GZT6-F1 | 81.37 | 0.63 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 121 (showing top):
MODULE_255, MODULE_317, AACYNNNNTTCCS_UNKNOWN, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOCC_MITOCHONDRIAL_ENVELOPE, ZHANG_BREAST_CANCER_PROGENITORS_UP, BERNARD_PPAPDC1B_TARGETS_UP, LEE_LIVER_CANCER_E2F1_DN, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4, NUYTTEN_EZH2_TARGETS_DN, MODULE_69, RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN, GOCC_ORGANELLE_ENVELOPE, BRUINS_UVC_RESPONSE_LATE, MODULE_37
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial membrane (GO:0031966), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrion | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
486 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC90B | FAM32A | Q9Y421 | 592 |
| CCDC90B | NIPAL2 | Q9H841 | 566 |
| CCDC90B | TRMT1L | Q7Z2T5 | 557 |
| CCDC90B | ANKRD42 | Q8N9B4 | 534 |
| CCDC90B | MRPL53 | Q96EL3 | 517 |
| CCDC90B | WDR74 | Q6RFH5 | 495 |
| CCDC90B | IGSF22 | Q8N9C0 | 487 |
| CCDC90B | RAB30 | Q15771 | 476 |
| CCDC90B | CXorf65 | A6NEN9 | 473 |
| CCDC90B | SMCO2 | A6NFE2 | 471 |
| CCDC90B | MICU1 | Q9BPX6 | 466 |
| CCDC90B | LRRC66 | Q68CR7 | 458 |
| CCDC90B | NOB1 | Q9ULX3 | 457 |
| CCDC90B | TMX1 | Q9H3N1 | 456 |
| CCDC90B | C11orf52 | Q96A22 | 446 |
IntAct
63 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MOB2 | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC90B | GORASP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC90B | YWHAG | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC90B | SETDB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KAT5 | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO3 | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC90B | MCUR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCUR1 | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC90B | TK1 | psi-mi:“MI:0915”(physical association) | 0.550 |
| TSC22D1 | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.550 |
| CTSV | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.400 |
| CCDC90B | psi-mi:“MI:0915”(physical association) | 0.370 | |
| CCDC90B | ANXA7 | psi-mi:“MI:0915”(physical association) | 0.370 |
| DNM2 | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.370 |
| NIPSNAP3A | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.370 |
| PIN1 | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.370 |
| SMN1 | CCDC90B | psi-mi:“MI:0915”(physical association) | 0.370 |
| HSPA4 | HSPA8 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC25A16 | TOMM70 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (230): MCUR1 (Affinity Capture-MS), MCUR1 (Affinity Capture-MS), ACTBL2 (Affinity Capture-MS), CCDC90B (Synthetic Lethality), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid), CCDC90B (Two-hybrid)
ESM2 similar proteins: A4QP73, A5DAI1, A8X0L4, A8XDF8, A9UQS1, B4IK33, E5KGE0, F4I111, O14042, O42997, O60065, O74552, O74925, O80996, O94308, O94689, P43557, P87150, Q05867, Q09743, Q09777, Q10073, Q10410, Q19954, Q21121, Q22505, Q23679, Q3SZ76, Q4V897, Q54LT0, Q618H8, Q626S1, Q6CTB6, Q6DJ87, Q6FIK2, Q6S5G3, Q751P7, Q8C3X2, Q8S9K7, Q8SYD0
Diamond homologs: Q0P4J6, Q4V897, Q6DJ87, Q8C3X2, Q96AQ8, Q9CXD6, Q9GZT6, Q10073
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 46 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1169 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:83273642:TTTAC:T | donor_loss | 1.0000 |
| 11:83273643:TTA:T | donor_loss | 1.0000 |
| 11:83273645:A:AT | donor_loss | 1.0000 |
| 11:83273646:C:CG | donor_loss | 1.0000 |
| 11:83273701:C:CC | acceptor_gain | 1.0000 |
| 11:83273787:CATTA:C | donor_loss | 1.0000 |
| 11:83273788:ATTAC:A | donor_loss | 1.0000 |
| 11:83273789:TTACC:T | donor_loss | 1.0000 |
| 11:83273790:TAC:T | donor_loss | 1.0000 |
| 11:83273791:A:T | donor_loss | 1.0000 |
| 11:83273792:C:CA | donor_loss | 1.0000 |
| 11:83273797:T:C | donor_gain | 1.0000 |
| 11:83273861:CATG:C | acceptor_gain | 1.0000 |
| 11:83273865:C:CC | acceptor_gain | 1.0000 |
| 11:83273866:T:C | acceptor_gain | 1.0000 |
| 11:83273993:C:CC | acceptor_gain | 1.0000 |
| 11:83274635:TCACC:T | donor_loss | 1.0000 |
| 11:83274636:CAC:C | donor_loss | 1.0000 |
| 11:83274638:CC:C | donor_loss | 1.0000 |
| 11:83274640:T:TA | donor_gain | 1.0000 |
| 11:83274695:T:A | donor_gain | 1.0000 |
| 11:83274737:TTTC:T | acceptor_gain | 1.0000 |
| 11:83274738:TTC:T | acceptor_gain | 1.0000 |
| 11:83274739:TC:T | acceptor_gain | 1.0000 |
| 11:83274740:CC:C | acceptor_gain | 1.0000 |
| 11:83274741:C:CC | acceptor_gain | 1.0000 |
| 11:83274741:CTAGA:C | acceptor_loss | 1.0000 |
| 11:83274742:T:C | acceptor_loss | 1.0000 |
| 11:83280083:A:C | donor_gain | 1.0000 |
| 11:83280189:T:A | donor_gain | 1.0000 |
AlphaMissense
1682 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:83274663:A:C | F134L | 0.996 |
| 11:83274663:A:T | F134L | 0.996 |
| 11:83274665:A:G | F134L | 0.996 |
| 11:83261952:A:G | C242R | 0.993 |
| 11:83274655:A:G | L137P | 0.991 |
| 11:83278812:C:G | A80P | 0.988 |
| 11:83261933:C:T | G248E | 0.987 |
| 11:83261942:A:T | I245K | 0.985 |
| 11:83265867:G:T | A236E | 0.985 |
| 11:83274679:A:G | L129P | 0.983 |
| 11:83265898:A:G | S226P | 0.982 |
| 11:83261934:C:G | G248R | 0.981 |
| 11:83261934:C:T | G248R | 0.981 |
| 11:83273955:A:G | L155P | 0.980 |
| 11:83274669:A:C | S132R | 0.980 |
| 11:83274669:A:T | S132R | 0.980 |
| 11:83274671:T:G | S132R | 0.980 |
| 11:83261945:G:T | A244E | 0.979 |
| 11:83274694:T:A | K124I | 0.979 |
| 11:83265906:A:G | L223P | 0.978 |
| 11:83274716:C:G | A117P | 0.978 |
| 11:83280178:A:C | F61L | 0.978 |
| 11:83280178:A:T | F61L | 0.978 |
| 11:83280180:A:G | F61L | 0.978 |
| 11:83274664:A:C | F134C | 0.977 |
| 11:83265870:A:G | L235P | 0.976 |
| 11:83274721:A:G | L115P | 0.976 |
| 11:83261942:A:C | I245R | 0.975 |
| 11:83261939:G:T | A246E | 0.974 |
| 11:83274662:C:G | A135P | 0.972 |
dbSNP variants (sampled 300 via entrez): RS1000036127 (11:83267472 C>G,T), RS1000118027 (11:83272858 T>C), RS1000144707 (11:83273451 G>A), RS1000229576 (11:83273361 G>C), RS1000392429 (11:83266996 C>T), RS1000410319 (11:83267299 G>A), RS1000465380 (11:83280622 G>A), RS1000595982 (11:83286288 G>A), RS1000773248 (11:83263277 A>C), RS1000844136 (11:83280368 C>A), RS1000897487 (11:83286484 T>C), RS1001014047 (11:83268223 CATA>C), RS1001201333 (11:83261130 C>G,T), RS1001268331 (11:83272926 C>T), RS1001447741 (11:83272693 A>T)
Disease associations
OMIM: gene MIM:620753 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_244 | Refractive error | 2.000000e-53 |
| GCST010135_38 | Oily fish consumption | 9.000000e-09 |
| GCST010140_28 | Pork consumption | 9.000000e-09 |
| GCST010703_247 | Brain morphology (MOSTest) | 2.000000e-14 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
36 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, decreases methylation | 4 |
| Aflatoxin B1 | affects expression, decreases methylation, increases expression | 4 |
| sodium arsenite | decreases expression, increases expression | 3 |
| Particulate Matter | decreases reaction, increases expression, decreases expression, increases abundance | 2 |
| dicrotophos | decreases expression | 1 |
| chloroacetaldehyde | affects expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | increases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases reaction, increases expression | 1 |
| bisphenol S | affects expression | 1 |
| MT19c compound | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Cidofovir | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Vehicle Emissions | decreases reaction, increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Demecolcine | increases expression | 1 |
| Clodronic Acid | decreases expression | 1 |
| Doxorubicin | affects expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Ifosfamide | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Oxygen | affects expression | 1 |
| Plant Extracts | increases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.